Live Breaking News & Updates on Prescribing information

Stay informed with the latest breaking news from Prescribing information on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Prescribing information and stay connected to the pulse of your community

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

Recommendation based on results from CheckMate -901, the first Phase 3 trial with an immunotherapy-chemotherapy combination to demonstrate a survival benefit versus standard-of-care chemotherapy...

United-states , Japan , Taiwan , South-korea , China , Bristol-myers-squibb , Dana-walker , European-medicines-agency , Company-opdivo , Twitter , Instagram , Global-program

U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B

A one-time dose of BEQVEZ has reduced bleeds post-treatment compared to standard of care with a median of zero bleeds after up to three years of follow-up, providing sustained bleed protection and...

United-states , Canada , Adam-cuker , Thromb-haemost , Kim-phelan , Aamir-malik , Drug-administration , Linkedin , Pfizer-inc , Hemophilia-thrombosis-program , Facebook , Pfizer

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Matthew-henson , Barry-greene , Ashley-kaplowitz , National-pregnancy-registry-for-antidepressants , Sage-therapeutics-inc , European-medicines-agency , Biogen-inc , Nasdaq , Regulatory-agency

Ionis Publishes 2023 Corporate Responsibility Report

Established new corporate responsibility strategic pillars and actionable goals Received approval for two Ionis-discovered medicines in 2023, and continued to advance a broad pipeline poised to...

California , United-states , Delaware , Hayley-soffer , D-wade-walke , Ionis-pharmaceuticals-inc , Nasdaq , Cr-steering-committee , Prnewswire-ionis-pharmaceuticals-inc , Astrazeneca , Corporation-law , Linkedin

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...

United-states , Spain , Switzerland , Barcelona , Comunidad-autonoma-de-cataluna , America , Kevin-garey , Eugenie-basseres , Davidp-luci , Society-or-healthcare-epidemiology-of-america , Exchange-commission , Research-scientist

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Switzerland , America , Kevin-garey , Eugenie-basseres , Davidp-luci , Acurx-pharmaceuticals-announces-presentation-of-ibezapolostat-phase , Nasdaq , University-of-houston-college-pharmacy

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John-tucker , York-heart-association , Katherine-mirandascpharmaceuticals-inc , Company-annual-report-on-form , Nasdaq , Pharmaceuticals-inc , Exchange-commission , Supplemental-new-drug-application , On-body-infusor , Chief-executive-officer , New-york-heart-association , Prescribing-information

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Katherine-miranda , John-tucker , York-heart-association , Pharmaceuticals-inc , Exchange-commission , Company-annual-report-on-form , Nasdaq , Pivotal-pharmacokinetic-study , Supplemental-new-drug-application , On-body-infusor , Chief-executive-officer , New-york-heart-association

Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a ...

Oral presentation will feature new data for investigational REGN7075, an EGFRxCD28 costimulatory bispecific with the potential to enhance the treatment of certain advanced solid tumors in combination with Libtayo® (cemiplimab-rwlc)

Chicago , Illinois , United-states , Canada , Brazil , American , Vesna-tosic , Taylor-skott , Regeneron-velocimmune , Georged-yancopoulos , Velocimmune-technology , Drug-administration

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Philadelphia , Pennsylvania , American , Christopher-moertel , Bruno-vincenzi , Jim-cassidy , Samantha-hilson-sandler , Bernd-kasper , American-society-of-clinical-oncology , European-commission , Us-department-of-commerce